Detalhe da pesquisa
1.
Clinical significance and safety of combined treatment with chemotherapy and pulmonary rehabilitation regarding health-related quality of life and physical function in nontuberculous mycobacterial pulmonary disease.
Respir Investig
; 60(5): 674-683, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35843830
2.
Decreased incremental shuttle walk test distance characterized by fibrocavitary lesions in non-tuberculous mycobacterial pulmonary disease.
Expert Rev Respir Med
; 16(4): 469-475, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35245168
3.
Influence of chronic sputum symptoms on quality of life in patients with nontuberculous mycobacterial pulmonary disease: A cross-sectional study.
Respir Investig
; 60(2): 277-283, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34764045
4.
Effects of pain on depression, sleep, exercise tolerance, and quality of life in patients with nontuberculous mycobacterial pulmonary disease.
Medicine (Baltimore)
; 100(23): e26249, 2021 Jun 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34115015
5.
Enhancement of energy expenditure following a single oral dose of flavan-3-ols associated with an increase in catecholamine secretion.
PLoS One
; 9(11): e112180, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25375880
6.
Alteration of the systemic and microcirculation by a single oral dose of flavan-3-ols.
PLoS One
; 9(4): e94853, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24740211
7.
Azithromycin may inhibit interleukin-8 through suppression of Rac1 and a nuclear factor-kappa B pathway in KB cells stimulated with lipopolysaccharide.
J Periodontol
; 82(11): 1623-31, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21417583